Thursday, May 18, 2017
- 5:30PM-7:00PM
-
Abstract Number: 102
Duration of High-Dose Aspirin Therapy Does Not Affect Coronary Artery Outcomes in Kawasaki Disease
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 139
Dysregulation of miRNA in mononuclear cells of patients with enthesitis related arthritis
Genetics and Pathogenesis Poster Session- 5:30PM-7:00PM
-
Abstract Number: 77
Effectiveness of Childhood Vaccinations in CAPS Patients Treated With Canakinumab: Results From an Open-Label Phase III Extension Study
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 94
Effects of Age and Gender on Reference Levels of Biomarkers Comprising the Pediatric Renal Activity Index for Lupus Nephritis (p-RAIL)
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 111
Eosinophilic Fasciitis in Children: Clinical Course and Response to Treatment from Two Large Academic Centers
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 147
Epigenetic and Transcriptomic Profiling of Primary Juvenile Idiopathic Arthritis Patient Cells: Better Understanding of Disease Pathogenesis
Genetics and Pathogenesis Poster Session- 5:30PM-7:00PM
-
Abstract Number: 135
Epigenetic Profiling Of Juvenile Idiopathic Arthritis (JIA) Synovial Fluid Monocytes Points Towards a Role For Monocytes In Bone Damage
Genetics and Pathogenesis Poster Session- 5:30PM-7:00PM
-
Abstract Number: 119
Establishment of registry for pediatric rheumatic diseases in Japan: Pediatric Rheumatology International Collaboration Unit Registry (PRICURE) survey
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 64
Evaluating Levels of Activity and Health-Related Quality of Life in a Pilot Cohort of Youth Athletes with Juvenile Idiopathic Arthritis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 42
Evaluation of a Dosing Regimen for Tocilizumab in Patients Younger Than Two Years of Age With Systemic Juvenile Idiopathic Arthritis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 113
Exploring the role of pediatric rheumatologists in the diagnosis and management of autoimmune encephalitis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 141
Expression of Siglec-10 on Synovial Fluid CD14dim Monocytes Was Decreased in Juvenile Idiopathic Arthritis Patients
Genetics and Pathogenesis Poster Session- 5:30PM-7:00PM
-
Abstract Number: 73
Factors Associated with Etoposide Usage in Children with Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 66
Feasibility Testing of An Internet-Based Psycho-Educational Game for Children with Juvenile Idiopathic Arthritis and Their Parents
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 75
Ferritin:ESR, A Predictor of MAS?